Representing Fish & Wildlife Agencies Since 1902
Home About Us Where We Work Membership Our Partners Press Room Contact Us Careers
 

Drug Approval Working Group

Committee Description

The Drug Approval Working Group (DAWG) comprises members from state resource agencies of each major U.S. geographic region representing the interest of the Association's Fisheries and Water Resources Policy Committee; technical representatives of USDA, USGS, USFWS, and USFDA; and the National Coordinator for Aquaculture New Animal Drug Applications. The overall objective of the DAWG is to provide a forum and mechanism for the oversight and coordination of collaborative research, field tests, data collection, data analysis, and data submittals to the U.S. Food and Drug Administration's Center for Veterinary Medicine for approval of priority drugs for use in public and private aquaculture in the United States.

The DAWG is a partner in the Aquatic Animal Drug Approval Partnership (AADAP) Program established within the U.S. Fish and Wildlife Service’s National Fish Hatchery System.

AADAP Website

AADAP Home

Current newsletter issue

General news

 

AADAP Fact Sheets

Chloramine-T
Florfenicol AQUI-S
Diquat SE-MARK
LHRHa Oxytetracycline Immersion
Oxytetracycline Injectable Common Carp Pituitary
17a-methyltestosterone Formalin
Potassium Permanganate Copper Sulfate
Ovaplant Hydrogen Peroxide
Catfish Pituitary  

 

Drug Use Guidance

Quick Reference Guide for Drugs Approved for Use in Aquaculture

Links

 

DAWG Minutes and Agendas

Coming soon


back to Committee Descriptions